20110927-204900-pic-823375978.jpg - Washington Times
Skip to content

BITTER PILL: John Castellani, president and CEO of PhRMA, cautions against cutting from 12 years to seven the length of a patent on a company's new drug. (J.M. Eddins Jr./The Washington Times)

BITTER PILL: John Castellani, president and CEO of PhRMA, cautions against cutting from 12 years to seven the length of a patent on a company's new drug. (J.M. Eddins Jr./The Washington Times)

Featured Photo Galleries

10302012_4_10302012_4_hires

Bizarre border busts

Photos from the U.S. Customs and Border Protection of the most bizarre attempts at smuggling drugs and people